RecruitingNot ApplicableNCT07178873

Psychosocial Teleassistance Programme for Adults With Spina Bifida

Effects of a Psychosocial Teleassistance Programme for Adults With Spina Bifida


Sponsor

University of Deusto

Enrollment

35 participants

Start Date

Jun 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial assesses the effect of a telecare psychosocial intervention designed for adults with spina bifida. The intervention consists of 10 weekly 1.5-hour group sessions, followed by two 3-month follow-up sessions. Each group will consist of 6 to 7 individuals. The intervention is aimed at strengthening aspects of self-concept, self-esteem, social skills and aims at a reduction of symptomatology and a general improvement of psychological well-being.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria5

  • To be diagnosed with spina bifida by a specialist.
  • Being between 18 and 75 years old.
  • Having their informed consent or the informed consent of their legal guardians.
  • Having Spanish as one of their main languages.
  • Having access to a computer (with a camera, microphone and speakers integrated) and Internet connection to take part in the videoconferences.

Exclusion Criteria2

  • Age that is inconsistent with the established range.
  • The presence of any comorbid diagnosis or sensory deficit that would impede the effective execution of the intervention's activities.

Interventions

BEHAVIORALPsychosocial teleassistance intervention

The teleassistance psychosocial intervention involves 10 weekly 90-minute group sessions, with each group comprising 6 to 7 participants. These sessions are designed to enhance self-concept, self-esteem and social skills, reduce symptoms, and improve overall psychological well-being. Two follow-up sessions will be provided three months after the main program concludes.


Locations(1)

University of Deusto

Bilbao, Bizkaia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07178873


Related Trials